MIR-16 mediates trastuzumab and lapatinib response in ERBB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.
03
Feb
MIR-16 mediates trastuzumab and lapatinib response in ERBB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1.
Venturutti L1, Cordo Russo RI, Rivas MA, Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M, Proietti CJ, Yankilevich P, Roa JC, Guzmán P, Cortese E, Allemand DH, Huang TH, Charreau EH, Cidlowski JA, Schillaci R, Elizalde PV2.
03
Feb
Circulating microrRNAs as biomarkers in biliary tract cancers
Letelier P1, Riquelme I, Hernández AH, Guzmán N, Farías JG, Roa JC2
03
Feb
RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver x receptor and lipid metabolism in gallbladder cancer
Zuo M1, Rashid A, Wang Y, Jain A, Li D, Behari A, Kapoor VK, Koay EJ, Chang P, Vauthey JN, Li Y, Espinoza JA, Roa JC, Javle M2
03
Feb
The gene expression status of the PI3K/AKT/mTOR pathway in gastric cancer tissues and cell lines
Riquelme I1, Tapia O, Espinoza JA, Leal P, Buchegger K, Sandoval A, Bizama C,Araya JC, Peek RM, Roa JC2
03
Feb
Salmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis.
Koshiol J1, Wozniak A, Cook P, Adaniel C, Acevedo J, Azócar L, Hsing AW, Roa JC, Pasetti MF, Miquel JF, Levine MM, Ferreccio C2; Gallbladder Cancer Chile Working Group.
03
Feb
Chlorine isotopic composition of perchlorate in human urine as a means of distinguishing among exposure sources
Poghosyan A, Morel-Espinosa M, Valentin-Blasini L, Blount BC, Ferreccio C, Steinmaus CM, Sturchio NC